Novartis bets $9.7bn on pivot to cardiovascular disease
Novartis announces bolt-on acquisition of Medicines Co., which adds the latter company’s sole drug candidate, inclisiran, to its CVD pipeline.
Archives for November 25, 2019
Recipharm strikes £505M takeover of Consort
Recipharm strikes £505m takeover of Consort Medical to leapfrog into top tier of CDMOs.
Zosano readies contract manufacturers for pre-approval inspections
Zosano Pharma prepares contract manufacturers to host pre-approval inspections to support filing for approval of migraine drug.
Heraeus adds ‘much-needed’ capacity for chemo components manufacture
Heraeus adds production line to expand its capacity for the manufacture of platinum-based HPAPIs.